Follow
Mark Hulett
Mark Hulett
La Trobe Institute for Molecular Science
Verified email at latrobe.edu.au
Title
Cited by
Cited by
Year
Cloning of mammalian heparanase, an important enzyme in tumor invasion and metastasis
MD Hulett, C Freeman, BJ Hamdorf, RT Baker, MJ Harris, CR Parish
Nature medicine 5 (7), 803-809, 1999
8401999
Comparative proteomics evaluation of plasma exosome isolation techniques and assessment of the stability of exosomes in normal human blood plasma
H Kalra, CG Adda, M Liem, CS Ang, A Mechler, RJ Simpson, MD Hulett, ...
Proteomics 13 (22), 3354-3364, 2013
6762013
Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches
JA Welsh, DCI Goberdhan, L O'Driscoll, EI Buzas, C Blenkiron, ...
Journal of extracellular vesicles 13 (2), e12404, 2024
6742024
Heparanase: a key enzyme involved in cell invasion
CR Parish, C Freeman, MD Hulett
Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1471 (3), M99-M108, 2001
6642001
Molecular basis of Fc receptor function
MD Hulett, PM Hogarth
Advances in immunology 57, 1-127, 1994
6601994
Molecular mechanisms of late apoptotic/necrotic cell clearance
IKH Poon, MD Hulett, CR Parish
Cell Death & Differentiation 17 (3), 381-397, 2010
4312010
Histidine‐rich glycoprotein: a novel adaptor protein in plasma that modulates the immune, vascular and coagulation systems
AL Jones, MD Hulett, CR Parish
Immunology and cell biology 83 (2), 106-118, 2005
3772005
A novel mechanism of generating extracellular vesicles during apoptosis via a beads-on-a-string membrane structure
GK Atkin-Smith, R Tixeira, S Paone, S Mathivanan, C Collins, M Liem, ...
Nature communications 6 (1), 7439, 2015
3712015
Immunotherapy of cytotoxic T cell–resistant tumors by T helper 2 cells: an eotaxin and STAT6-dependent process
J Mattes, M Hulett, W Xie, S Hogan, ME Rothenberg, P Foster, C Parish
The Journal of experimental medicine 197 (3), 387-393, 2003
3232003
Crystal structure of the human leukocyte Fc receptor, FcγRIIa.
KF Maxwell, MS Powell, MD Hulett, PA Barton, IFC McKenzie, TPJ Garrett, ...
Nature structural biology 6 (5), 437-442, 1999
2961999
Endothelial cell apoptosis and the role of endothelial cell-derived extracellular vesicles in the progression of atherosclerosis
S Paone, AA Baxter, MD Hulett, IKH Poon
Cellular and Molecular Life Sciences 76, 1093-1106, 2019
2752019
Histidine-rich glycoprotein: the Swiss Army knife of mammalian plasma
IKH Poon, KK Patel, DS Davis, CR Parish, MD Hulett
Blood, The Journal of the American Society of Hematology 117 (7), 2093-2101, 2011
2572011
Soluble heparan sulfate fragments generated by heparanase trigger the release of pro-inflammatory cytokines through TLR-4
KJ Goodall, IKH Poon, S Phipps, MD Hulett
PloS one 9 (10), e109596, 2014
2462014
Phosphoinositide-mediated oligomerization of a defensin induces cell lysis
IKH Poon, AA Baxter, FT Lay, GD Mills, CG Adda, JAE Payne, TK Phan, ...
Elife 3, e01808, 2014
2082014
Convergent evolution of defensin sequence, structure and function
TMA Shafee, FT Lay, TK Phan, MA Anderson, MD Hulett
Cellular and Molecular Life Sciences 74, 663-682, 2017
2062017
Identification of active-site residues of the pro-metastatic endoglycosidase heparanase
MD Hulett, JR Hornby, SJ Ohms, J Zuegg, C Freeman, JE Gready, ...
Biochemistry 39 (51), 15659-15667, 2000
2002000
The defensins consist of two independent, convergent protein superfamilies
TMA Shafee, FT Lay, MD Hulett, MA Anderson
Molecular biology and evolution 33 (9), 2345-2356, 2016
1522016
The MS4A family: counting past 1, 2 and 3
L Eon Kuek, M Leffler, GA Mackay, MD Hulett
Immunology and cell biology 94 (1), 11-23, 2016
1442016
FC receptor for immunoglobulin
IFC McKenzie, MP Hogarth, ML Hibbs, BM Scott, L Bonadonna, MD Hulett
US Patent 5,985,599, 1999
1421999
Identification of residues in the first domain of human Fcα receptor essential for interaction with IgA
BD Wines, MD Hulett, GP Jamieson, HM Trist, JM Spratt, PM Hogarth
The Journal of Immunology 162 (4), 2146-2153, 1999
1411999
The system can't perform the operation now. Try again later.
Articles 1–20